ICON plc (ADR) (NASDAQ:ICLR)

CAPS Rating: 3 out of 5

The Company is a contract research organization, providing clinical research and development services on a global basis to the pharmaceutical, biotechnology and medical device industries.

Recs

0
Player Avatar stockguy07 (< 20) Submitted: 8/13/2008 1:59:56 PM : Outperform Start Price: $41.65 ICLR Score: -53.03

TM - drug trial outsourcing

Featured Broker Partners


Advertisement